BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 26851024)

  • 1. High PTPRQ Expression and Its Relationship to Expression of PTPRZ1 and the Presence of KRAS Mutations in Colorectal Cancer Tissues.
    Laczmanska I; Karpinski P; Gil J; Laczmanski L; Bebenek M; Sasiadek MM
    Anticancer Res; 2016 Feb; 36(2):677-81. PubMed ID: 26851024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copy number alterations of chromosomal regions enclosing protein tyrosine phosphatase receptor-like genes in colorectal cancer.
    Laczmanska I; Karpinski P; Kozlowska J; Bebenek M; Ramsey D; Sedziak T; Ziolkowski P; Sasiadek MM
    Pathol Res Pract; 2014 Dec; 210(12):893-6. PubMed ID: 25169130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein tyrosine phosphatase receptor-like genes are frequently hypermethylated in sporadic colorectal cancer.
    Laczmanska I; Karpinski P; Bebenek M; Sedziak T; Ramsey D; Szmida E; Sasiadek MM
    J Hum Genet; 2013 Jan; 58(1):11-5. PubMed ID: 23096495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies to target energy metabolism in consensus molecular subtype 3 along with Kirsten rat sarcoma viral oncogene homolog mutations for colorectal cancer therapy.
    Wang G; Wang JJ; Yin PH; Xu K; Wang YZ; Shi F; Gao J; Fu XL
    J Cell Physiol; 2019 May; 234(5):5601-5612. PubMed ID: 30341899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal poorly differentiated neuroendocrine carcinomas frequently exhibit BRAF mutations and are associated with poor overall survival.
    Olevian DC; Nikiforova MN; Chiosea S; Sun W; Bahary N; Kuan SF; Pai RK
    Hum Pathol; 2016 Mar; 49():124-34. PubMed ID: 26826419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KRAS Status as an Independent Prognostic Factor for Survival after Yttrium-90 Radioembolization Therapy for Unresectable Colorectal Cancer Liver Metastases.
    Lahti SJ; Xing M; Zhang D; Lee JJ; Magnetta MJ; Kim HS
    J Vasc Interv Radiol; 2015 Aug; 26(8):1102-11. PubMed ID: 26210240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KRAS and aneusomy of chromosomes 4, 10 and 12 in colorectal carcinomas.
    Beyer K; Altendorf-Hofmann A; Chen Y; Bickel K; Petersen I
    Pathol Res Pract; 2015 Sep; 211(9):646-51. PubMed ID: 26122820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between DPYD gene variation and KRAS wild type status in colorectal cancer.
    Kleist B; Kempa M; Meurer T; Poetsch M
    J Clin Pathol; 2016 Mar; 69(3):204-8. PubMed ID: 26281864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline MAPK signaling activity confers intrinsic radioresistance to KRAS-mutant colorectal carcinoma cells by rapid upregulation of heterogeneous nuclear ribonucleoprotein K (hnRNP K).
    Eder S; Arndt A; Lamkowski A; Daskalaki W; Rump A; Priller M; Genze F; Wardelmann E; Port M; Steinestel K
    Cancer Lett; 2017 Jan; 385():160-167. PubMed ID: 27793696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein tyrosine phosphatase RQ is a phosphatidylinositol phosphatase that can regulate cell survival and proliferation.
    Oganesian A; Poot M; Daum G; Coats SA; Wright MB; Seifert RA; Bowen-Pope DF
    Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7563-8. PubMed ID: 12802008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein tyrosine phosphatase receptor R and Z1 expression as independent prognostic indicators in oral squamous cell carcinoma.
    Duś-Szachniewicz K; Woźniak M; Nelke K; Gamian E; Gerber H; Ziółkowski P
    Head Neck; 2015 Dec; 37(12):1816-22. PubMed ID: 25043478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical and Western blot analysis of two protein tyrosine phosphatase receptors, R and Z1, in colorectal carcinoma, colon adenoma and normal colon tissues.
    Woźniak M; Gamian E; Łaczmańska I; Sąsiadek MM; Duś-Szachniewicz K; Ziółkowski P
    Histol Histopathol; 2014 May; 29(5):635-9. PubMed ID: 24242166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tyrosine phosphatases as a superfamily of tumor suppressors in colorectal cancer.
    Laczmanska I; Sasiadek MM
    Acta Biochim Pol; 2011; 58(4):467-70. PubMed ID: 22146137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of wild-type p21Ras plays a prominent role in colorectal cancer.
    Bai S; Feng Q; Pan XY; Zou H; Chen HB; Wang P; Zhou XL; Hong YL; Song SL; Yang JL
    Int J Mol Med; 2017 Apr; 39(4):861-868. PubMed ID: 28259994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased expression of the RAS-GTPase activating protein RASAL1 is associated with colorectal tumor progression.
    Ohta M; Seto M; Ijichi H; Miyabayashi K; Kudo Y; Mohri D; Asaoka Y; Tada M; Tanaka Y; Ikenoue T; Kanai F; Kawabe T; Omata M
    Gastroenterology; 2009 Jan; 136(1):206-16. PubMed ID: 18992247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal cancer-related mutant KRAS alleles function as positive regulators of autophagy.
    Alves S; Castro L; Fernandes MS; Francisco R; Castro P; Priault M; Chaves SR; Moyer MP; Oliveira C; Seruca R; Côrte-Real M; Sousa MJ; Preto A
    Oncotarget; 2015 Oct; 6(31):30787-802. PubMed ID: 26418750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel compound heterozygous mutation in PTPRQ in a DFNB84 family with prelingual sensorineural hearing impairment.
    Sang Q; Mei H; Kuermanhan A; Feng R; Guo L; Qu R; Xu Y; Li H; Jin L; He L; Wang L
    Mol Genet Genomics; 2015 Jun; 290(3):1135-9. PubMed ID: 25557914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher metastatic efficiency of KRas G12V than KRas G13D in a colorectal cancer model.
    Alamo P; Gallardo A; Di Nicolantonio F; Pavón MA; Casanova I; Trias M; Mangues MA; Lopez-Pousa A; Villaverde A; Vázquez E; Bardelli A; Céspedes MV; Mangues R
    FASEB J; 2015 Feb; 29(2):464-76. PubMed ID: 25359494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis for the dephosphorylating activity of PTPRQ towards phosphatidylinositide substrates.
    Yu KR; Kim YJ; Jung SK; Ku B; Park H; Cho SY; Jung H; Chung SJ; Bae KH; Lee SC; Kim BY; Erikson RL; Ryu SE; Kim SJ
    Acta Crystallogr D Biol Crystallogr; 2013 Aug; 69(Pt 8):1522-9. PubMed ID: 23897475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTPRZ1 regulates calmodulin phosphorylation and tumor progression in small-cell lung carcinoma.
    Makinoshima H; Ishii G; Kojima M; Fujii S; Higuchi Y; Kuwata T; Ochiai A
    BMC Cancer; 2012 Nov; 12():537. PubMed ID: 23170925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.